Ultragenyx Analyst Day Presentation

Keys to our success: Experienced team focused on innovation, speed, and execution Deep scientific understanding increases probability of success 82% demonstrate clinical success First ever regulatory and development approaches Approved products based on novel trial designs and endpoints Fastest development in the industry Global commercial organization Avg 5.5 yrs from clinic to approval Treating patients in ~34 countries 5 Confidential and Proprietary ultragenyx

View entire presentation